03/03/2021
In response to the USA Today article (3/3/21) criticizing Seresto Collars, Elanco Animal Health, the producers of Seresto Collars, released the following statement:
Elanco Statement of Safety of Seresto®
Elanco takes the safety of our products very seriously, and thoroughly investigates potential concerns related to their use. It is critically important to understand that a report is not an indication of cause. Since its initial approval in 2012, Seresto has protected more than 25 million U.S. dogs and cats from fleas, ticks and the resulting tick-borne illnesses that can impact their quality of life.
The incident report rate for all adverse events related to Seresto is less than 0.3% of all collars sold since 2012 - defined by the WHO (World Health Organization) as “uncommon”. The significant majority of these incidents relate to non-serious effects such as application site disorders – reddening of the skin or hair loss below the collar. More than 80 regulatory authorities around the world, including the U.S. EPA, rigorously reviewed and approved Seresto, confirming Seresto is safe and effective when used according to label instructions.
For further reading, see the article linked below from The Canine Review, which provides perspective from a Pet Specialty News Outlet.
THE CANINE REVIEW'S mission is to provide fair, complete, and unvarnished information related to dogs. We believe that caregivers and vendors devoted to treating dog owners and their loved ones professionally and fairly deserve a spotlight – as do those who operate outside those important boundari...
